期刊文献+

慢性阻塞性肺疾病新指南对临床患者分类的应用价值 被引量:16

Clinical application value of the new guide for patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)2013年西班牙新指南新临床分型的临床意义。方法回顾收集2009年1月至2014年12月安徽医科大学附属安庆市立医院呼吸内科收治的确诊COPD患者640例的临床资料,按照2013年西班牙指南的分型方法将其分为A、B、C、D四组,对各组的肺功能和血气分析指标、合并症的发生率及抗生素、激素的使用量进行分析比较。结果 C组和D组的肺功能指标第一秒用力呼气容积(FEV1)、第一秒用力呼气容积/用力肺活量(FEV1%)明显低于A组和B组(P<0.05);糖尿病、高血压在各组中患病比例差异无统计学意义(P>0.05);而冠心病、心律失常、心力衰竭在C、D组比例明显高于A组和B组(P<0.05),其在D组中比例高于C组(P<0.05)。A、B组抗生素的使用时间明显低于C、D组(P<0.05),D组的抗生素使用时间显著高于C组(P<0.05)。B组激素使用量高于其他组(P<0.05),C、D组的激素使用量高于A组(P<0.05)。D组的住院时间在各组中最高,而A组的住院时间最短。D组在机械通气、机械通气时间、病死率上明显高于其他组(P<0.05)。结论新指南的临床分型有重要指导作用,需要深入研究来验证其临床价值。 Objective To investigate the clinical significance of the clinical classification of the Spanish newclinical guidelines in chronic obstructive pulmonary disease( COPD) in 2013. Methods A total of 640 cases who had been diagnosed as COPD and hospitalized in the department of respiratory medicine of Anqing Municipal Hospital Affilicated to Anhui Medical University were collected from January 2009 to December 2014. According to the typing method of Spanish guidelines in 2013,the 640 cases were divided into four groups named A,B,C and D respectively. The pulmonary function,index of analysis of blood gas,morbidity of complication,the usage of antibiotics and hormone of each group were analyzed and compared. Results Pulmonary function forced expiratory volume in one second( FEV1) and forced expiratory volume in one second/forced vital capacity( FEV1%) in groups C and D were significantly lower than those in groups A and B( P〈0. 05). There was no significant difference in each group about the morbidity of diabetes and hypertension( P〉0. 05),while the incidence of coronary heart disease,arrhythmia and heart failure in groups C and D were significantly higher than those in groups A and B( P〈0. 05),and in group D higher than in group C( P〈0. 05). The usage time of antibiotics in groups A and B were significantly lower than that in groups C and D( P〈0. 05),and in group D was obviously higher than in group C( P〈0. 05). The use amount of hormone in group B was higher than that in groups A,C and D( P〈0. 05),and in groups C and D higher than in group A( P〈0. 05). In all groups,hospitalization time in group D was longest and shortest in group A. Usage of mechanicalventilation,mechanical ventilation time and mortality rate in group D was significantly higher than that in other groups( P〈0. 05). Conclusion The clinical classification of the newguidelines has important guiding role,but it needs further studies to verify its clinical value.
作者 潘青 吕志芳
出处 《山东大学学报(医学版)》 CAS 北大核心 2016年第3期63-67,共5页 Journal of Shandong University:Health Sciences
关键词 慢性阻塞性肺疾病 西班牙新指南 临床分型 Chronic obstructive pulmonary disease Spanish newclinical guidelines Clinical classification
  • 相关文献

参考文献15

  • 1Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4): 347-365. 被引量:1
  • 2Davis KJ, Landis SH, Oh YM, et al. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries[J]. Int J Chron Obstruct Pulmon Dis, 2014, 10: 39-55. 被引量:1
  • 3金哲,王广发.慢性阻塞性肺疾病全球倡议(2014更新版)解读[J].中国医学前沿杂志(电子版),2014,6(2):94-97. 被引量:140
  • 4李仰瑞,熊伟,赵伟,丁薇,赵云峰.心血管合并症对老年慢性阻塞性肺疾病患者急性加重及预后的影响[J].老年医学与保健,2014,20(6):400-402. 被引量:7
  • 5Calverley PM, Anderson JA, Celli B, et al. Cardiovascular events in patients with COPD: TORCH study results[J]. Thorax, 2010, 65(8):719-725. 被引量:1
  • 6孙奥松,单守勤.CT冠状动脉成像与钙化积分结合评价冠心病的价值[J].实用放射学杂志,2014,30(3):425-429. 被引量:10
  • 7Beran D, Zar HJ, Perrin C, et al. Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries[J]. Lancet Respir Med, 2015, 3(2): 159-170. 被引量:1
  • 8Miravitlles M, Soler-Catalu?a JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines(GesEPOC)[J]. Prim Care Respir J, 2013, 22(1): 117-121. 被引量:1
  • 9Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD[J]. Am J Respir Crit Care Med, 2010, 182(5):598-604. 被引量:1
  • 10Soriano JB, Davis KJ, Coleman B, et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom[J]. Chest, 2003, 124(2): 474-481. 被引量:1

二级参考文献20

  • 1陈建,王广发.慢性阻塞性肺疾病全球倡议2011修订版解读[J].中国医学前沿杂志(电子版),2012,4(1):42-44. 被引量:65
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3Jadwiga A Wedzicha,Marc Decramer,Joachim H Ficker,Dennis E Niewoehner,Thomas Sandstr?m,Angel Fowler Taylor,Peter D’Andrea,Christie Arrasate,Hungta Chen,Donald Banerji.Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study[J].The Lancet Respiratory Medicine.2013(3) 被引量:1
  • 4Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a popu- lation-based prevalence study [J]. Lancet, 2007, 370 (9589): 741-750. 被引量:1
  • 5Soriano JB, Larnpreclat B. Chronic obstructive pulmonary disease: a worldwide problem [J]. Med Clin North Am, 2012, 96 (4):671-680. 被引量:1
  • 6Calverley PM, Anderson JA, Celli B, et al. Cardiovascular events in patients with COPD: TORCH study results [J]. Thorax, 2010, 65 (8): 719-725. 被引量:1
  • 7Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease m patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients [J]. Ann Epidemiol, 2006, 16 (1): 63-70. 被引量:1
  • 8Zvezdin B, Milutinov S, Kojicic M, et al. A postmortem ananlysis of major causes of early death in patients hospitalized with COPDexacerbation [J]. Chest, 2009, 136 (2): 376-380. 被引量:1
  • 9Anthonisen NR, ConnettJE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study [J]. JAMA, 1994, 272 (19): 1497-1505. 被引量:1
  • 10Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD [J]. Chest, 2005,128 (4): 2640-2646. 被引量:1

共引文献154

同被引文献138

引证文献16

二级引证文献117

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部